MRC1 and breast carcinoma: To our knowledge, this is the first study from Azerbaijan to investigate the MLH1 −93G>A polymorphism in breast cancer patients, offering new evidence on genetic risk within this underrepresented population and contributing to the broader understanding of MMR gene variants in carcinogenesis.